NO20021909D0 - Anvendelse av 2-imidazolylsubstituerte karbinoler for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander - Google Patents

Anvendelse av 2-imidazolylsubstituerte karbinoler for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander

Info

Publication number
NO20021909D0
NO20021909D0 NO20021909A NO20021909A NO20021909D0 NO 20021909 D0 NO20021909 D0 NO 20021909D0 NO 20021909 A NO20021909 A NO 20021909A NO 20021909 A NO20021909 A NO 20021909A NO 20021909 D0 NO20021909 D0 NO 20021909D0
Authority
NO
Norway
Prior art keywords
prophylaxis
imidazolyl
medicament
manufacture
treatment
Prior art date
Application number
NO20021909A
Other languages
English (en)
Other versions
NO20021909L (no
Inventor
Andreas Weichert
Udo Albus
Hans-Willi Jansen
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20021909D0 publication Critical patent/NO20021909D0/no
Publication of NO20021909L publication Critical patent/NO20021909L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20021909A 1999-10-27 2002-04-23 Anvendelse av 2-imidazolylsubstituerte karbinoler for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander NO20021909L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951701A DE19951701A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
PCT/EP2000/010126 WO2001030327A2 (de) 1999-10-27 2000-10-14 Verwendung von 2-imidazolyl-substituierten carbinolen zur herstellung eines medikaments zur behandlung oder prophylaxe von durch ischämischen zuständen

Publications (2)

Publication Number Publication Date
NO20021909D0 true NO20021909D0 (no) 2002-04-23
NO20021909L NO20021909L (no) 2002-04-23

Family

ID=7927020

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021909A NO20021909L (no) 1999-10-27 2002-04-23 Anvendelse av 2-imidazolylsubstituerte karbinoler for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander

Country Status (30)

Country Link
US (1) US6291502B1 (no)
EP (1) EP1227811B1 (no)
JP (1) JP2003512419A (no)
KR (1) KR20020060213A (no)
CN (1) CN1188125C (no)
AR (1) AR026241A1 (no)
AT (1) ATE257702T1 (no)
AU (1) AU778836B2 (no)
BR (1) BR0015024A (no)
CA (1) CA2388956A1 (no)
CZ (1) CZ295925B6 (no)
DE (2) DE19951701A1 (no)
DK (1) DK1227811T3 (no)
EE (1) EE200200218A (no)
ES (1) ES2213621T3 (no)
HK (1) HK1048938B (no)
HR (1) HRP20020362A2 (no)
HU (1) HUP0203213A3 (no)
IL (1) IL149208A0 (no)
NO (1) NO20021909L (no)
NZ (1) NZ518586A (no)
PL (1) PL355911A1 (no)
PT (1) PT1227811E (no)
RU (1) RU2257205C2 (no)
SK (1) SK5512002A3 (no)
TR (1) TR200201140T2 (no)
TW (1) TWI246424B (no)
WO (1) WO2001030327A2 (no)
YU (1) YU20902A (no)
ZA (1) ZA200203035B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726829B2 (en) * 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
EP1911740B1 (en) * 2002-01-04 2013-02-27 NeuroSearch A/S Potassium channel modulators
US10040767B2 (en) 2014-05-15 2018-08-07 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
US4152441A (en) 1972-02-04 1979-05-01 Gist-Brocades N.V. Analgesic imidazolemethanols
BE794940A (fr) * 1972-02-04 1973-08-02 Gist Brocades Nv Nouveaux composes anorexigenes
US5063220A (en) * 1988-10-21 1991-11-05 Syntex Pharmaceuticals, Ltd. Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6175013B1 (en) * 1994-06-10 2001-01-16 Eli Lilly And Company Imidazolinyl tachykinin receptor antagonists
CA2258165C (en) 1996-06-27 2009-03-03 Marc Gaston Venet N-[4-(heteroarylmethyl)phenyl]-heteroarylamines

Also Published As

Publication number Publication date
AU778836B2 (en) 2004-12-23
YU20902A (sh) 2004-11-25
AR026241A1 (es) 2003-02-05
IL149208A0 (en) 2002-11-10
PL355911A1 (en) 2004-05-31
ATE257702T1 (de) 2004-01-15
BR0015024A (pt) 2002-06-18
HK1048938A1 (en) 2003-04-25
CZ20021452A3 (cs) 2002-07-17
JP2003512419A (ja) 2003-04-02
ES2213621T3 (es) 2004-09-01
CN1188125C (zh) 2005-02-09
WO2001030327A3 (de) 2002-03-14
DE50005040D1 (de) 2004-02-19
HRP20020362A2 (en) 2004-02-29
RU2257205C2 (ru) 2005-07-27
DE19951701A1 (de) 2001-05-03
SK5512002A3 (en) 2002-08-06
EP1227811A2 (de) 2002-08-07
US6291502B1 (en) 2001-09-18
TWI246424B (en) 2006-01-01
ZA200203035B (en) 2003-03-14
NZ518586A (en) 2004-07-30
KR20020060213A (ko) 2002-07-16
DK1227811T3 (da) 2004-04-19
NO20021909L (no) 2002-04-23
HUP0203213A3 (en) 2003-07-28
AU1138201A (en) 2001-05-08
CA2388956A1 (en) 2001-05-03
CZ295925B6 (cs) 2005-11-16
CN1373663A (zh) 2002-10-09
TR200201140T2 (tr) 2002-11-21
WO2001030327A2 (de) 2001-05-03
HK1048938B (zh) 2005-06-10
EE200200218A (et) 2003-06-16
HUP0203213A2 (en) 2003-05-28
PT1227811E (pt) 2004-05-31
EP1227811B1 (de) 2004-01-14
RU2002113666A (ru) 2004-01-10

Similar Documents

Publication Publication Date Title
NO20033594D0 (no) Fenetanolamin-derivater for behandling av luftveissykdommer
CY2014019I1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
NO20031442D0 (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
NO20031443D0 (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20020764D0 (no) Benzoesyrederivater for behandling av diabetes mellitus
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20031615D0 (no) Pyrazol-derivater for behandling av virus-sykdommer
HK1104460A1 (en) Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases
NO995245L (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
NO973243D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer
HUP0303988A2 (hu) Azitromicin alkalmzása nem fertőző gyulladásos betegségek kezelésére szolgáló gyógyszerkészítmény előállítására
NO20025394D0 (no) Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmonire sykdommer
NO20021909D0 (no) Anvendelse av 2-imidazolylsubstituerte karbinoler for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander
NO20020784D0 (no) Medikament for behandling av brudd
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20021710D0 (no) Anvendelse av 2-amino-3,4-dihydro-kinazoliner for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
NO20014777D0 (no) Fremgangsmåte for behandling av flyveaske under anvendelse av saltsyre
HK1077216A1 (en) Use of thiazole derivatives for the manufacture ofa medicament for the treatment of chronic obstruc tive pulmonary disease